Induction ICI Combination Followed by CRT Is An Effective Bladder-Sparing Treatment in Patients with MIBC and Response Can Be Monitored by ctDNA By Ogkologos - March 12, 2026 204 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the INDIBLADE study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of Renal Cell Carcinoma How Decades of NCI Support Led to Groundbreaking Discoveries: The Story of Immune Checkpoint Inhibitors Adding Belzutifan to Pembrolizumab Prolongs DFS After Nephrectomy in Patients with ccRCC at Increased Risk for Recurrence MOST POPULAR Study Finds Accelerated Partial-Breast Radiation Just as Effective as Whole Breast... December 13, 2019 Research with integrity – referencing work is way more than just... May 3, 2023 EMA Recommends Granting a Conditional Marketing Authorisation for Repotrectinib November 27, 2024 FDA Approves First Immunotherapy Treatment For Breast Cancer March 11, 2019 Load more HOT NEWS Trial Establishes Preferred Treatment for Some People with Esophageal Cancer What Are Biosimilars in Cancer Treatment? EMA Recommends Granting a Marketing Authorisation Under Exceptional Circumstances for Moxetumomab... Increased Risk of Cancer in Early Life Among Individuals with Autism...
